{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2022,4,1]],"date-time":"2022-04-01T03:42:58Z","timestamp":1648784578644},"reference-count":30,"publisher":"Springer Science and Business Media LLC","issue":"S2","license":[{"start":{"date-parts":[[2014,11,1]],"date-time":"2014-11-01T00:00:00Z","timestamp":1414800000000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Pathologe"],"published-print":{"date-parts":[[2014,11]]},"DOI":"10.1007\/s00292-014-1986-z","type":"journal-article","created":{"date-parts":[[2014,11,14]],"date-time":"2014-11-14T07:29:56Z","timestamp":1415950196000},"page":"237-241","update-policy":"http:\/\/dx.doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":1,"title":["Neue molekulare Aspekte der Chordome"],"prefix":"10.1007","volume":"35","author":[{"given":"S.","family":"Scheil-Bertram","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2014,11,15]]},"reference":[{"key":"1986_CR1","doi-asserted-by":"crossref","first-page":"334","DOI":"10.1002\/path.2913","volume":"224","author":"Amary","year":"2011","unstructured":"Amary MF, Bacsi K, Maggiani F et al (2011) IDH1 and IDH2 mutations are frequent events in central chondrosarcoma and central and periosteal chondromas but not in other mesenchymal tumours. J Pathol 224:334\u2013343","journal-title":"J Pathol"},{"key":"1986_CR2","doi-asserted-by":"crossref","unstructured":"Akhavan-Sigari R, Gaab MR, Rohde V et al (2014) Prognostic significance of immunohistochemical expression of VEGFR2 and iNOS in spinal chordoma. Eur Spine J (Epub ahead of print)","DOI":"10.1007\/s00586-014-3417-5"},{"key":"1986_CR3","first-page":"623","volume":"34","author":"Akhavan-Sigari","year":"2014","unstructured":"Akhavan-Sigari R, Gaab MR, Rohde V et al (2014) Expression of PDGFR-\u03b1, EGFR and c-MET in spinal chordoma: a series of 52 patients. Anticancer Res 34:623\u2013630","journal-title":"Anticancer Res"},{"key":"1986_CR4","doi-asserted-by":"crossref","first-page":"980","DOI":"10.3109\/0284186X.2013.878472","volume":"53","author":"Asklund","year":"2014","unstructured":"Asklund T, Sandstr\u00f6m M, Shahidi S et al (2014) Durable stabilization of three chordoma cases by bevacizumab and erlotinib. Acta Oncol 53:980\u2013984","journal-title":"Acta Oncol"},{"key":"1986_CR5","doi-asserted-by":"crossref","first-page":"514753","DOI":"10.1155\/2014\/514753","volume":"2014","author":"Barresi","year":"2014","unstructured":"Barresi V, Ieni A, Branca G, Tuccari G (2014) Brachyury: a diagnostic marker for the differential diagnosis of chordoma and hemangioblastoma versus neoplastic histological mimickers. Dis Markers 2014:514753","journal-title":"Dis Markers"},{"key":"1986_CR6","doi-asserted-by":"crossref","first-page":"1747","DOI":"10.1016\/j.humpath.2012.11.024","volume":"44","author":"Castro","year":"2013","unstructured":"Castro CV de, Guimaraes G, Aguiar S Jr et al (2013) Tyrosine kinase receptor expression in chordomas: phosphorylated AKT correlates inversely with outcome. Hum Pathol 44:1747\u20131755","journal-title":"Hum Pathol"},{"key":"1986_CR7","doi-asserted-by":"crossref","first-page":"886","DOI":"10.1007\/s12032-014-0886-7","volume":"31","author":"Chen","year":"2014","unstructured":"Chen K, Mo J, Zhou M, Wang G et al (2014) Expression of PTEN and mTOR in sacral chordoma and association with poor prognosis. Med Oncol 31:886","journal-title":"Med Oncol"},{"key":"1986_CR8","doi-asserted-by":"crossref","first-page":"e101283","DOI":"10.1371\/journal.pone.0101283","volume":"9","author":"Choy","year":"2014","unstructured":"Choy E, MacConaill LE, Cote GM et al (2014) Genotyping cancer-associated genes in chordoma identifies mutations in oncogenes and areas of chromosomal loss involving CDKN2 A, PTEN, and SMARCB1. PLoS One 9:e101283","journal-title":"PLoS One"},{"key":"1986_CR9","doi-asserted-by":"crossref","first-page":"518","DOI":"10.1111\/j.1600-0463.2009.02461.x","volume":"117","author":"Daugaard","year":"2009","unstructured":"Daugaard S, Christensen LH, H\u00f8gdall E (2009) Markers aiding the diagnosis of chondroid tumors: an immunohistochemical study including osteonectin, bcl-2, cox-2, actin, calponin, D2-40 (podoplanin), mdm-2, CD117 (c-kit), and YKL-40. APMIS 117:518\u2013525","journal-title":"APMIS"},{"key":"1986_CR10","doi-asserted-by":"crossref","first-page":"4","DOI":"10.1186\/2045-3329-1-4","volume":"25","author":"Dewaele","year":"2011","unstructured":"Dewaele B, Maggiani F, Floris G et al (2011) Frequent activation of EGFR in advanced chordomas. Clin Sarcoma Res 25:4","journal-title":"Clin Sarcoma Res"},{"key":"1986_CR11","doi-asserted-by":"crossref","first-page":"788","DOI":"10.1593\/neo.12526","volume":"14","author":"Diaz","year":"2012","unstructured":"Diaz RJ, Guduk M, Romagnuolo R et al (2012) High-resolution whole-genome analysis of skull base chordomas implicates FHIT loss in chordoma pathogenesis. Neoplasia 14:788\u2013798","journal-title":"Neoplasia"},{"key":"1986_CR12","unstructured":"Flanagan AM, Yamaguchi T (2013) WHO classification of tumours of soft tissue and bone. IARC Press, Lyon, S\u00a0328\u2013329"},{"key":"1986_CR13","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1016\/j.neuchi.2014.02.003","volume":"60","author":"George","year":"2014","unstructured":"George B, Bresson D, Bouazza S et al (2014) Chordoma. Neurochirurgie 60:63\u2013140","journal-title":"Neurochirurgie"},{"key":"1986_CR14","doi-asserted-by":"crossref","first-page":"434","DOI":"10.1038\/sj.bjc.6604130","volume":"98","author":"Hallor","year":"2008","unstructured":"Hallor KH, Staaf J, J\u00f6nsson G et al (2008) Frequent deletion of the CDKN2A locus in chordoma: analysis of chromosomal imbalances using array comparative genomic hybridisation. Br J Cancer 98:434\u2013442","journal-title":"Br J Cancer"},{"key":"1986_CR15","doi-asserted-by":"crossref","first-page":"760","DOI":"10.3171\/2011.5.JNS11185","volume":"115","author":"Hsu","year":"2011","unstructured":"Hsu W, Mohyeldin A, Shah SR et al (2011) Generation of chordoma cell line JHC7 and the identification of Brachyury as a novel molecular target. J Neurosurg 115:760\u2013769","journal-title":"J Neurosurg"},{"key":"1986_CR16","doi-asserted-by":"crossref","first-page":"1491","DOI":"10.1093\/carcin\/bgu014","volume":"35","author":"Hu","year":"2014","unstructured":"Hu Y, Mintz A, Shah SR et al (2014) The FGFR\/MEK\/ERK\/brachyury pathway is critical for chordoma cell growth and survival. Carcinogenesis 35:1491\u20131499","journal-title":"Carcinogenesis"},{"key":"1986_CR17","doi-asserted-by":"crossref","unstructured":"Kelley MJ, Shi J, Ballew B et al (2014) Characterization of T gene sequence variants and germline duplications in familial and sporadic chordoma. Hum Genet (Epub ahead of print)","DOI":"10.1007\/s00439-014-1463-z"},{"key":"1986_CR18","doi-asserted-by":"crossref","first-page":"e18846","DOI":"10.1371\/journal.pone.0018846","volume":"6","author":"Le","year":"2011","unstructured":"Le LP, Nielsen GP, Rosenberg AE et al (2011) Recurrent chromosomal copy number alterations in sporadic chordomas. PLoS One 6:e18846","journal-title":"PLoS One"},{"key":"1986_CR19","doi-asserted-by":"crossref","first-page":"104","DOI":"10.1002\/cncr.23141","volume":"112","author":"Naka","year":"2008","unstructured":"Naka T, Kuester D, Boltze C et al (2008) Expression of hepatocyte growth factor and c-MET in skull base chordoma. Cancer 112:104\u2013110","journal-title":"Cancer"},{"key":"1986_CR20","doi-asserted-by":"crossref","first-page":"274","DOI":"10.1002\/path.4082","volume":"228","author":"Nelson","year":"2012","unstructured":"Nelson AC, Pillay N, Henderson S et al (2012) An integrated functional genomics approach identifies the regulatory network directed by brachyury (T) in chordoma. J Pathol 228:274\u2013285","journal-title":"J Pathol"},{"key":"1986_CR21","doi-asserted-by":"crossref","first-page":"1185","DOI":"10.1038\/ng.2419","volume":"44","author":"Pillay","year":"2012","unstructured":"Pillay N, Plagnol V, Tarpey PS et al (2012) A common single-nucleotide variant in T is strongly associated with chordoma. Nat Genet 44:1185\u20131187","journal-title":"Nat Genet"},{"key":"1986_CR22","doi-asserted-by":"crossref","first-page":"327","DOI":"10.1002\/path.2816","volume":"223","author":"Presneau","year":"2011","unstructured":"Presneau N, Shalaby A, Ye H et al (2011) Role of the transcription factor T (brachyury) in the pathogenesis of sporadic chordoma: a genetic and functional-based study. J Pathol 223:327\u2013335","journal-title":"J Pathol"},{"key":"1986_CR23","doi-asserted-by":"crossref","first-page":"1041","DOI":"10.3892\/ijo.2014.2268","volume":"44","author":"Scheil-Bertram","year":"2014","unstructured":"Scheil-Bertram S, Kappler R, Baer A von et al (2014) Molecular profiling of chordoma. Int J Oncol 44(4):1041\u20131055","journal-title":"Int J Oncol"},{"key":"1986_CR24","doi-asserted-by":"crossref","first-page":"336","DOI":"10.1002\/path.2818","volume":"223","author":"Shalaby","year":"2011","unstructured":"Shalaby A, Presneau N, Ye H et al (2011) The role of epidermal growth factor receptor in chordoma pathogenesis: a potential therapeutic target. J Pathol 223:336\u2013346","journal-title":"J Pathol"},{"key":"1986_CR25","doi-asserted-by":"crossref","first-page":"e78895","DOI":"10.1371\/journal.pone.0078895","volume":"8","author":"Siu","year":"2013","unstructured":"Siu IM, Ruzevick J, Zhao Q et al (2013) Erlotinib inhibits growth of a patient-derived chordoma xenograft. PLoS One 8:e78895","journal-title":"PLoS One"},{"key":"1986_CR26","doi-asserted-by":"crossref","first-page":"1931","DOI":"10.1093\/annonc\/mdt117","volume":"24","author":"Stacchiotti","year":"2013","unstructured":"Stacchiotti S, Tamborini E, Lo Vullo S et al (2013) Phase II study on lapatinib in advanced EGFR-positive chordoma. Ann Oncol 24:1931\u20131966","journal-title":"Ann Oncol"},{"key":"1986_CR27","doi-asserted-by":"crossref","first-page":"914","DOI":"10.1200\/JCO.2011.35.3656","volume":"30","author":"Stacchiotti","year":"2012","unstructured":"Stacchiotti S, Longhi A, Ferraresi V et al (2012) Phase II study of imatinib in advanced chordoma. J Clin Oncol 30:914\u2013920","journal-title":"J Clin Oncol"},{"key":"1986_CR28","doi-asserted-by":"crossref","first-page":"261","DOI":"10.1002\/path.4102","volume":"228","author":"Szuhai","year":"2012","unstructured":"Szuhai K, Hogendoorn PC (2012) \u201aThe chicken or the egg?\u2018 dilemma strikes back for the controlling mechanism in chordoma(#). J Pathol 228:261\u2013265","journal-title":"J Pathol"},{"key":"1986_CR29","doi-asserted-by":"crossref","unstructured":"Uhl M, Mattke M, Welzel T et al (2014) Highly effective treatment of skull base chordoma with carbon ion irradiation using a raster scan technique in 155 patients: first long-term results. Cancer. doi:10.1002\/cncr.28877 (Epub ahead of print)","DOI":"10.1002\/cncr.28877"},{"key":"1986_CR30","doi-asserted-by":"crossref","first-page":"e91546","DOI":"10.1371\/journal.pone.0091546","volume":"9","author":"Zhang","year":"2014","unstructured":"Zhang Y, Schiff D, Park D, Abounader R (2014) MicroRNA-608 and microRNA-34a regulate chordoma malignancy by targeting EGFR, Bcl-xL and MET. PLoS One 9:e91546","journal-title":"PLoS One"}],"container-title":["Der Pathologe"],"original-title":[],"language":"de","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00292-014-1986-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s00292-014-1986-z\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00292-014-1986-z","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,8,17]],"date-time":"2019-08-17T06:08:00Z","timestamp":1566022080000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s00292-014-1986-z"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2014,11]]},"references-count":30,"journal-issue":{"issue":"S2","published-print":{"date-parts":[[2014,11]]}},"alternative-id":["1986"],"URL":"https:\/\/doi.org\/10.1007\/s00292-014-1986-z","relation":{},"ISSN":["0172-8113","1432-1963"],"issn-type":[{"value":"0172-8113","type":"print"},{"value":"1432-1963","type":"electronic"}],"subject":[],"published":{"date-parts":[[2014,11]]}}}